\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes European Digital Innovation HubsThe official portal of the network of European Digital Innovation Hubs is now online.
The EDIH Network is currently comprised of 136 EDIHs that are co-funded by the European Commission´s Digital Europe Programme. Its core mission is to build up the digital capacities of SMEs and public sector organisations throughout the European Union. To accelerate digital transformation, the EDIH Network is focused on building capacity and leveraging cutting-edge technologies in key sectors in every European Union Member State.
This website is managed by the Digital Transformation Accelerator (DTA), which has the objective to foster networking, cooperation and knowledge transfer activities between EDIH, SME and mid-caps, the public sector and the other relevant stakeholders and initiatives.
The website gathers information on the EDIHs, the Network, EDIH support services and how to benefit from these services.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
